145 related articles for article (PubMed ID: 1396891)
1. Randomized double blind trial of Ambroxol for the treatment of respiratory distress syndrome.
Wauer RR; Schmalisch G; Böhme B; Arand J; Lehmann D
Eur J Pediatr; 1992 May; 151(5):357-63. PubMed ID: 1396891
[TBL] [Abstract][Full Text] [Related]
2. Ambroxol in the treatment of idiopathic respiratory distress syndrome. An interim report on a controlled double-blind multicenter study versus placebo.
Marini A; Franzetti M; Gios G; Flauto U; Arosio A; Maccabruni M; Rondini G; Chirico G; Giancola A; Console V
Respiration; 1987; 51 Suppl 1():60-7. PubMed ID: 3299568
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.
Smyth J; Allen A; MacMurray B; Peliowski A; Sankaran K; Volberg F; Shukla A; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S81-9. PubMed ID: 7745516
[TBL] [Abstract][Full Text] [Related]
4. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
Schmalisch G; Wauer RR; Böhme B
Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
[TBL] [Abstract][Full Text] [Related]
5. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
6. Changes in pulmonary function in preterm infants recovering from RDS following early treatment with ambroxol: results of a randomized trial.
Schmalisch G; Wauer RR; Böhme B
Pediatr Pulmonol; 1999 Feb; 27(2):104-12. PubMed ID: 10088933
[TBL] [Abstract][Full Text] [Related]
7. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
McMillan D; Chernick V; Finer N; Schiff D; Bard H; Watts J; Krzeski R; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S90-8. PubMed ID: 7745517
[TBL] [Abstract][Full Text] [Related]
8. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
Durand M; Sardesai S; McEvoy C
Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
[TBL] [Abstract][Full Text] [Related]
9. Antenatal ambroxol treatment does not prevent the respiratory distress syndrome in premature infants.
Dani C; Grella PV; Lazzarin L; Rubaltelli FF
Eur J Pediatr; 1997 May; 156(5):392-3. PubMed ID: 9177984
[TBL] [Abstract][Full Text] [Related]
10. Early dexamethasone-attempting to prevent chronic lung disease.
Sinkin RA; Dweck HS; Horgan MJ; Gallaher KJ; Cox C; Maniscalco WM; Chess PR; D'Angio CT; Guillet R; Kendig JW; Ryan RM; Phelps DL
Pediatrics; 2000 Mar; 105(3 Pt 1):542-8. PubMed ID: 10699107
[TBL] [Abstract][Full Text] [Related]
11. Antenatal ambroxol usage in the prevention of infant respiratory distress syndrome. Beneficial and adverse effects.
Kimya Y; Küçükkömürcü S; Ozan H; Uncu G
Clin Exp Obstet Gynecol; 1995; 22(3):204-11. PubMed ID: 7554258
[TBL] [Abstract][Full Text] [Related]
12. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
13. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant.
Bose C; Corbet A; Bose G; Garcia-Prats J; Lombardy L; Wold D; Donlon D; Long W
J Pediatr; 1990 Dec; 117(6):947-53. PubMed ID: 2246698
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide in premature infants with the respiratory distress syndrome.
Schreiber MD; Gin-Mestan K; Marks JD; Huo D; Lee G; Srisuparp P
N Engl J Med; 2003 Nov; 349(22):2099-107. PubMed ID: 14645637
[TBL] [Abstract][Full Text] [Related]
15. [Surfactant and ambroxol in the therapy of idiopathic respiratory syndrome in newborn infants].
Carrera G; Liberatore A; Riboni G; Clementi M
Minerva Pediatr; 1991 Nov; 43(11):723-30. PubMed ID: 1791799
[TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
[TBL] [Abstract][Full Text] [Related]
17. Polymorphonuclear leucocytes functions from premature infants after prevention of respiratory distress syndrome with betamethasone and ambroxol.
Lazzarin A; Luerti M; Uberti-Foppa C; Zavattini G; Rossi A; Tornaghi R
Biol Res Pregnancy Perinatol; 1984; 5(3):130-4. PubMed ID: 6478010
[TBL] [Abstract][Full Text] [Related]
18. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
19. Inositol supplementation in premature infants with respiratory distress syndrome.
Hallman M; Bry K; Hoppu K; Lappi M; Pohjavuori M
N Engl J Med; 1992 May; 326(19):1233-9. PubMed ID: 1560798
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
